Increased Density of the Liver and Amiodarone-Associated Phospholipidosis
This is a case report in which a 60-year-old man who suffered from ventricular tachycardia with dilated cardiomyopathy was prescribed amiodarone. After taking amiodarone, liver enzymes were increased and computed tomographic (CT) scanning of the abdomen showed a significant increase in the density o...
Main Authors: | Sunao Kojima, Shinobu Kojima, Hirofumi Ueno, Motohiro Takeya, Hisao Ogawa |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2009-01-01
|
Series: | Cardiology Research and Practice |
Online Access: | http://dx.doi.org/10.4061/2009/598940 |
Similar Items
-
Amiodarone Hepatotoxicity with Absent Phospholipidosis and Steatosis: A Case Report and Review of Amiodarone Toxicity in Various Organs
by: Adela Cimic, et al.
Published: (2013-01-01) -
Comparison of Oral, Intranasal and Aerosol Administration of Amiodarone in Rats as a Model of Pulmonary Phospholipidosis
by: Aateka Patel, et al.
Published: (2019-07-01) -
Predicting the mechanism of phospholipidosis
by: Lowe Robert, et al.
Published: (2012-01-01) -
Attenuation of amiodarone induced lung fibrosis and phospholipidosis in hamsters, by treatment with the platelet activating factor receptor antagonist, WEB 2086
by: S. N. Giri, et al.
Published: (1993-01-01) -
Use of 3D Human Liver Organoids to Predict Drug-Induced Phospholipidosis
by: Ji-Young Lee, et al.
Published: (2020-04-01)